目的:分析术前18F-氟代脱氧葡萄糖正电子发射/计算机断层显像(18F-fluorodeoxyglucose positron emission/computed tomography,18F-FDG PET/CT)中盆腔淋巴结最大标准化摄取值(maximal standardized up-take value,SUVmax)联合中性粒细胞与淋巴细胞比值(neutrophil to lymphocyte ratio,NLR)对根治性膀胱切除术(rad cal cystectomy,RC)患者淋巴结转移的预测价值.方法:回顾性分析2017年1月-2023年12月于首都医科大学附属北京友谊医院接受RC且术前1个月内行18F-FDG PET/CT检查的85例患者的临床资料和病理资料,最终纳入66例患者,根据术后病理结果,分为淋巴结转移组(14例)和淋巴结非转移组(52例).收集患者18F-FDG PET/CT淋巴结SUVmax及术前1周内血常规结果,计算NLR及血小板与淋巴细胞比值(platelet to lym-phocyte ratio,PLR),以淋巴结SUVmax≥2作为影像学转移截断值.应用受试者工作特征(ROC)曲线分析淋巴结SUVmax、NLR及两者联合曲线下面积(AUC).结果:淋巴结转移组患者病理T分期、SUVmax、NLR、PLR明显高于非转移组患者(P<0.01).多因素logistic回归分析结果显示患者病理T分期、淋巴结SUVmax及NLR是预测病理淋巴结转移的独立危险因素(均P<0.05).ROC曲线显示以SUVmax≥2预测患者病理淋巴结转移的AUC为0.753(95%CI:0.626~0.879),灵敏度和特异度分别为92.9%和57.7%,阳性预测值和阴性预测值分别为37.1%和96.8%;NLR预测患者病理淋巴结转移的AUC为0.867(95%CI:0.759~0.975),根据约登指数,计算NLR最佳截断值为2.5,此时灵敏度和特异度分别为92.9%和73.1%,阳性预测值和阴性预测值分别为40.9%和97.4%;联合SUVmax和NLR后,预测病理淋巴结转移AUC为0.906(95%CI:0.816~0.995),灵敏度和特异度分别为85.7%和90.4%,阳性预测值和阴性预测值分别为70.6%和95.9%.结论:18F-FDG PET/CT淋巴结SUVmax及NLR可预测RC患者病理淋巴结转移的发生,两者联合诊断对淋巴结转移的预测价值更高.
Value of preoperative 18F-FDG PET/CT combined with neutrophil to lymphocyte ratio in predicting lymph node metastasis in patients undergoing radical cystectomy
Objective:To evaluate the predictive value of 18 F-fluorodeoxyglucose positron emission/computed tomography(18F-FDG PET/CT)combined with neutrophil to lymphocyte ratio(NLR)for lymph node metastasis in patents undergoing radical cystectomy.Methods:A retrospective analysis was conducted on 85 patients who underwent radical cystectomy and 18 F-FDG PET/CT examination one month before surgery at Beijing Friendship Hospital from January 2017 to December 2023.Based on inclusion and exclusion criteria,66 patients were includ-ed.They were divided into lymph node metastasis group(n=14)and lymph node non-metastasis group(n=52).The 18 F-FDG PET/CT lymph node SUVmax and NLR were collected.Lymph node SUVmax≥2 was considered as imaging metastasis.ROC curve was performed to analyze the area under curve of lymph node SUVmax,NLR and the combination of both.Results:Pathological T stage,SUVmax,NLR and platelet to lymphocyte ratio in lymph node metastasis group were significantly higher than those in non-metastatic group(P<0.01).Multivariate logistic regression analysis showed that pathological T stage,lymph node SUVmax and NLR were independent risk factors in predicting pathological lymph node metastasis(P<0.05).ROC curve revealed that the AUC of SUVmax≥2 to predict pathological lymph node metastasis was 0.753(95%CI:0.626-0.879).The sensitivity and specificity were 92.9%and 57.7%,respectively,and the positive predictive value(PPV)and negative predic-tive value(NPV)were 37.1%and 96.8%,respectively.NLR predicted that the AUC of patients with pathologi-cal lymph node metastasis was 0.867(95%CI:0.759-0.975).According to the Youden index,the optimal cut-off value of NLR was 2.5.The sensitivity and specificity were 92.9%and 73.1%,respectively,and the PPV and NPV were 40.9%and 97.4%,respectively.Combined SUVmax and NLR,the AUC for predicting pathological lymph node metastasis was 0.906(95%CI:0.816-0.995).The sensitivity and specificity were 85.7%and 90.4%,and the PPV and NPV were 70.6%and 95.9%,respectively.Conclusion:Both 18F-FDG PET/CT and NLR can predict the occurrence of pathological lymph node metastasis in patients undergoing radical cystectomy,and the combined method is more valuable in diagnosis.